Very nice explanation of the little guys vs. the big guys. Will health insurance companies realize that perhaps paying for this drug in the short term saves them money in the long term? Maybe, maybe not.....jury is still out.
The market is huge. LLY will want to own the space and all the IP so they may buy VKTX. LLY and NVO are NOT overpriced. It's a $70 billion annual revenue market. Super disruptive drug - the medical community will be changed forever due to this new technology.
The next Viking could be Altimmune, they have good obesity data, they are at 12 dollars at the moment. They have good results and with more results their stock price will rise. Full disclosure, I have 60 shares of Viking which I bought 2 months ago, and 507 shares of Altimmune.
@@kingkohli4952 shareholder here. I’m no analyst but from what I understand, seems like it has good support at 70, and with any relevant good news (M&A solid rumor, new developments on their trials, etc) it could easily go past previous high of 90 and maybe cross 100. I think it’s a good price to hold onto those shares. (no financial advice)
People been waiting on a fat loss drug for forever. My problem is that its created shortages for people who actually need medication for their diabetes.
Very nice explanation of the little guys vs. the big guys. Will health insurance companies realize that perhaps paying for this drug in the short term saves them money in the long term? Maybe, maybe not.....jury is still out.
Hope this doesn't cost $1,000 per month. Insurance companies would rather pay for heart attack and stroke medical costs later on.
The market is huge. LLY will want to own the space and all the IP so they may buy VKTX. LLY and NVO are NOT overpriced. It's a $70 billion annual revenue market. Super disruptive drug - the medical community will be changed forever due to this new technology.
lol I bought five shares a year back because it was like 5$ and the name sounded cool. I should’ve bought more.
The next Viking could be Altimmune, they have good obesity data, they are at 12 dollars at the moment. They have good results and with more results their stock price will rise. Full disclosure, I have 60 shares of Viking which I bought 2 months ago, and 507 shares of Altimmune.
Is 68$ good price point for Viking? What do you predict the market price? Maybe in a year?
@@kingkohli4952 I honestly couldn’t tell you. lol I was just an idiot that got lucky.
@@kingkohli4952 shareholder here. I’m no analyst but from what I understand, seems like it has good support at 70, and with any relevant good news (M&A solid rumor, new developments on their trials, etc) it could easily go past previous high of 90 and maybe cross 100. I think it’s a good price to hold onto those shares. (no financial advice)
The real money is consumer one recession buy at discount.
The hottest drugs are fat loss 😂. We must be near the end of civilization
Obesity is the cause of many serious health conditions.
People been waiting on a fat loss drug for forever. My problem is that its created shortages for people who actually need medication for their diabetes.
How about this for a thought, put the fork down!
Yeah I’m sure all their data is absolutely honest, reliable, and expensive. Give me a break.